← Open Payments lookup

SHARON DUDLEY-BROWN: Open Payments

NPI 1427057272 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,993 in 61 payments from 10 companies in 2025. Trend: 2023 $14,308 · 2024 $18,123 · 2025 $8,993

Consulting: $3,781Speaker / faculty: $3,500Food & beverage: $1,587Travel & lodging: $125
CompanyPaymentsAmount
ABBVIE INC.22$5,029
Janssen Biotech, Inc.12$2,106
Takeda Pharmaceuticals U.S.A., Inc.13$1,543
PFIZER INC.5$84
Lilly USA, LLC2$66
Janssen Scientific Affairs, LLC1$40
Phathom Pharmaceuticals, Inc.2$40
Celltrion USA Inc.2$34
GENZYME CORPORATION1$26
Intercept Pharmaceuticals, Inc.1$25

Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, OMVOH, VELSIPITY, VOQUEZNA, VEGZELMA.

Industry payments across MD — which companies pay providers there.